test44
https://www.cytel.com/news/rocheqba
July 5, 2022
WALTHAM, MASS - Cytel Inc. and F. Hoffman-La Roche Ltd., have partnered together to pioneer the application of a unique..
Read article
test44
https://www.cytel.com/news/cytel-designed-and-led-together-trial-wins-society-of-clinical-trials-david-sackett-trial-of-the-year-award
May 17, 2022
WALTHAM, MASS - The TOGETHER Trial for COVID-19 therapies, designed by clinical trial specialists at Cytel Inc., has..
Read article
test44
https://www.cytel.com/news/closing-the-biometrics-skills-and-services-gap-in-australia
test44
https://www.cytel.com/news/guardian-research-network-and-cytel-announce-presentation-at-ispor-2022-detailing-covid-19s-impact-on-breast-cancer
April 27, 2022
Joint efforts recognize the global pandemic impact on the staging of cancer cases in the United States at the..
Read article
test44
https://www.cytel.com/news/scientific-computing-world-cytel-appoints-first-cmo-to-accelerate-the-expansion-of-analytics-and-innovation
test44
https://www.cytel.com/news/reuters-health-information-covers-cytels-economic-model-for-lgbtq-study
test44
https://www.cytel.com/news/cytel-appoints-first-cmo-propelling-expansion-of-analytics-and-innovation-available-to-clinicians-in-drug-development
March 22, 2022
WALTHAM, MASS - Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving..
Read article
test44
https://www.cytel.com/news/wall-street-journal-reports-finding-of-cytel-designed-covid-19-trial
test44
https://www.cytel.com/news/new-york-daily-news-features-cytel-study-widely-debunked-and-dangerous-lgbtq-conversion-therapy-costs-u.s.-9b-per-year-study-finds
